BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-596@pharmaconomics
DTSTAMP:20260707T033952Z
DTSTART;VALUE=DATE:20251231
DTEND;VALUE=DATE:20260101
SUMMARY:DYN Phase 1 — z-rostudirsen (estimated date)
DESCRIPTION:Phase 1 trial results for z-rostudirsen in Duchenne muscular dystrophy are due ~ Dec 31\, 2025. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1818794/000119312526084207/dyn-ex99_1.htm\n\nTrack it: https://www.pharmaconomics.com/e/596
URL:https://www.pharmaconomics.com/e/596
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:DYN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR